drugset / Trial / NCT00676806

A Phase II Study of Umbilical Cord Blood Transplantation

NCT00676806

Phase 2 Terminated 7 enrolled Tufts Medical Center
Non-randomizedParallel-groupOpen-labelTreatment

Summary

This study is designed to determine whether Umbilical Cord Transplantation (UCB) can be substituted for adult bone marrow cells in the standard stem cell transplant regimens used at this hospital for subjects who do not have stem cell donors.

Timeline

Start
2005-07
Primary completion
2013-07
Completion
2014-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Cyclophosphamide Other / unclassified 50 mg/kg
Subject Cyclophosphamide Other / unclassified 60 mg/m2
Subject Fludarabine Small molecule 25 mg/m2
Subject Influenza Virus Vaccine Vaccine
Subject Pentostatin Small molecule 4 mg/kg